BAJAJ FINSERV DIRECT LIMITED
Latest IPO Information

Avience Biomedicals Ltd. IPO

IPO Date: Jun 18 to Jun 22 2026

Listing Date: Jun 25 2026

Objective

1. Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh
2. Funding the Working Capital Requirement of our Company
3. To meet out the General Corporate Purposes

IPO Details

Face Value ₹ 10.00 Per Share
Issue Size ₹ 20.46 - 21.72 Cr
Price Band ₹ 196.00 - ₹ 208.00 Per Share
Market LOT 1200 shares
Issue Type Book building

About Company

Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) productsand medical devices in Noida, Uttar Pradesh, India. In vitro diagnostics (IVDs) are tests that can detect disease, conditions andinfections. In vitro simply means ‘in glass’, meaning these tests are typically conducted in test tubes and similar equipment, asopposed to in vivo tests, which are conducted in the body itself. In vitro tests can be done in laboratories, health care facilities oreven in the home. The tests themselves can be performed on a variety of instruments ra .... nging from small, handheld tests to complexlaboratory instruments.Avience Biomedicals Limited commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM),Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions withaffordable and good-quality solutions. Avience Biomedicals Limited has expanded its product range from IVD rapid test kits toinclude a comprehensive line of medical devices such as Serology products, Biochemistry Analyser and Biochemistry Reagents,showcasing a dedication to addressing various healthcare needs. Being purely into B2B and B2G market, our products cater toPathology Labs, Microbiology Labs, Hospitals, and Research Centers nationwide as well as overseas. In addition to manufacturing,the Company also act as distributors and traders of medical equipments Read More
Address

C-11, Block- C Community Centre Janakpuri A-3

City

New Delhi

State

Delhi

Pincode

110058

Phone

011-45699388

Email

info@avienbio.com

Website

www.avienbio.com

About IPO

Listed At NSE
Lead Manager Fintellectual Corporate Advisors Pvt Ltd.
Promoters
Ram Nagina Choudhary
Janardan Pal
Dharam Deo Choudhary
Deepa Choudhary

Promoter's Holding

Registrar

Skyline Financial Services Pvt Ltd

011-26847136/26833777

Latest News

Sep
24
2026
EQUITY Posted on Sep 24th 2026

CarTrade Tech informs about press release

CarTrade Tech has informed that it enclosed the press release titled ‘Landmark Cars and OLX India Partner to Build India's Leading Phygital Pre-Owned Car Platform’. The same is also made available on the website of the Company at https://www.cartradetech.com/. 
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
24
2026
EQUITY Posted on Sep 24th 2026

NCL Industries informs about loss of share certificate

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, NCL Industries has informed that it attached information received from its RTA regarding loss of Share certificate(s). A copy of the letter received from its RTA also attached.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
24
2026
EQUITY Posted on Sep 24th 2026

KNR Constructions informs about receipt of order

KNR Constructions has informed that the company is in receipt of order from Office of the Commissioner of Income Tax – Appeals - Hyderabad-12 and the details as required under Regulation 30 of SEBI (LODR) Regulations, 2015 are enclosed. 
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
24
2026
EQUITY Posted on Sep 24th 2026

FIIs were net sellers of Rs 3227.17 crore in index futures and options segments on September 23

According to the data released by the NSE, the Foreign Institutional Investors (FIIs) were net sellers of Rs 3227.17 crore in index futures and options segments, as per Wednesday’s data, September 23, 2026.

FIIs were net buyers of index futures to the tune of Rs 678.98 crore and net sellers of index options worth Rs 3906.15 crore. In the stock segment, FII’s were net buyers of stock futures worth Rs 349.05 crore and they sold stock options worth Rs 57.85 crore.

Read More
Sep
24
2026
EQUITY Posted on Sep 24th 2026

F&O total turnover stood at Rs 82,04,819.32 crore on September 23

Futures & Options (F&O) total turnover stood at 82,04,819.32 crore on September 23 and the total number of contracts traded on the day were 5,87,30,273.

Of the total turnover, Index Futures contributed Rs 8,995.52 crore, Stock Futures Rs 1,01,618.50 crore and Index Options Rs 75,01,070.68 crore, while the contribution of the Stock Options was of Rs 5,93,134.62 crore.

For the day, the total F&O Put Call ratio stood at 0.85, while the Index Options Put Call ratio was 0.93 and that of Stock Options was 0.50.

Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the issue size of Avience Biomedicals Ltd. IPO?

The issue size of Avience Biomedicals Ltd. IPO is ₹20.46 - 21.72 crore.

The Avience Biomedicals Ltd. IPO opens for subscription on 2026-06-18 and closes on 2026-06-22.

The price range of Avience Biomedicals Ltd. IPO is ₹196.00 to ₹208.00.

The lot size of Avience Biomedicals Ltd. IPO is 1200 shares.

The registrar of Avience Biomedicals Ltd. IPO is Skyline Financial Services Pvt Ltd .

Avience Biomedicals Ltd. IPO will be listed on NSE .

You will typically receive a confirmation message or notification from your broker or trading platform shortly after placing your IPO order. This confirms that your application has been submitted successfully. You can also check the order status in the IPO section of your trading account or app.

Apply early with valid UPI and PAN before 2026-06-22 to increase your chances.

The listing date of Avience Biomedicals Ltd. IPO is 2026-06-25.

An Initial Public Offering (IPO) is when a private company sells shares to the public for the first time, enabling investors to purchase these shares and gain partial ownership in the business. For instance, if a well-known tech firm wants to grow and requires additional funds, it might choose to go public through an IPO. During this process, investors can buy shares, and the company’s stock starts trading on the stock exchange on the day of the IPO listing.

Investors can apply for an IPO through their bank or brokerage account. Many trading platforms have a specific section for IPOs where users can submit their applications online.

The primary market is where shares are offered to the public for the first time via an IPO. After the IPO, shares are traded on the secondary market (stock exchange), where existing shareholders can sell to new buyers.

Investing in an IPO offers the opportunity to become an early investor in companies with high growth potential, at a price which may be lower than their post-listing market value. It provides a chance to participate in the company's growth journey from its early stages. However, IPO investments also come with inherent risks, such as market volatility and uncertainties about the company's future performance.

The price of an IPO is established through a systematic process known as "book building." In this method, investors bid within a given price range, and the final price is set based on demand and market conditions. Several factors play a crucial role in determining the IPO price, including:

Past Financial Performance: Evaluating the company's revenue, profits, and financial stability over time

Growth Potential: Assessing future prospects based on the company's business model and market opportunities

Industry Peers: Comparing valuation metrics with similar companies in the same sector

Larger Industry Picture: Analysing overall industry trends and economic conditions that could impact the company's performance

The lock-in period for IPO shares refers to a duration during which specific investors are restricted from selling their shares post-listing. This period varies based on the type of investor:

Promoters: The lock-in period for promoters ranges from 6 months to 18 months, ensuring their commitment to the company's long-term growth

Anchor Investors: Typically, anchor investors face a shorter lock-in period of 30 to 90 days, depending on regulatory norms and the specific IPO

IPOs can be volatile and may not perform as expected in the short term. Investors risk losing capital if the stock price drops after listing, especially if the company does not meet its growth projections.

Information on upcoming IPOs is often available through brokerage platforms, financial news sites, and regulatory bodies like SEBI, which publishes details on companies going public. You can also get these details under the upcoming IPO section on Bajaj Markets.

Eligibility for an IPO typically includes:

Retail Investors: Individuals who invest in smaller amounts, usually under the “retail investor” category, with certain limits

Qualified Institutional Buyers (QIBs): Entities like mutual funds, banks, and insurance companies, who invest large sums

Non-Institutional Investors (NIIs): High-net-worth individuals or entities investing above the retail threshold

Investors must have a Demat and trading account to apply, and in some cases, certain financial or residency qualifications may apply depending on local regulations.

SME (Small and Medium Enterprise) IPOs generally carry higher risk but may provide significant growth potential. Investors should research the company’s stability, financials, and sector risks, as SME stocks can be more volatile compared to large-cap companies.

View More

Invalid Mobile Number

Invalid Full Name

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore